LEMAITRE VASCULAR INC (LMAT)
US5255582018 - Common Stock
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 192 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a correct valuation and a medium growth rate. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
LMAT had a positive operating cash flow in the past year.
Each year in the past 5 years LMAT has been profitable.
LMAT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LMAT has a better Return On Assets (9.59%) than 91.71% of its industry peers.
LMAT has a Return On Equity of 11.01%. This is amongst the best in the industry. LMAT outperforms 87.05% of its industry peers.
LMAT's Return On Invested Capital of 9.45% is amongst the best of the industry. LMAT outperforms 89.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 8.42%.
The 3 year average ROIC (8.98%) for LMAT is below the current ROIC(9.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.59% | ||
| ROE | 11.01% | ||
| ROIC | 9.45% |
ROA(3y)8.17%
ROA(5y)8.48%
ROE(3y)9.46%
ROE(5y)10.55%
ROIC(3y)8.98%
ROIC(5y)9.18%
1.3 Margins
With an excellent Profit Margin value of 16.99%, LMAT belongs to the best of the industry, outperforming 93.78% of the companies in the same industry.
LMAT's Profit Margin has declined in the last couple of years.
LMAT's Operating Margin of 20.46% is amongst the best of the industry. LMAT outperforms 93.78% of its industry peers.
In the last couple of years the Operating Margin of LMAT has remained more or less at the same level.
Looking at the Gross Margin, with a value of 66.46%, LMAT is in the better half of the industry, outperforming 72.02% of the companies in the same industry.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.46% | ||
| PM (TTM) | 16.99% | ||
| GM | 66.46% |
OM growth 3Y-4.21%
OM growth 5Y-0.39%
PM growth 3Y-1.71%
PM growth 5Y-6.42%
GM growth 3Y0.15%
GM growth 5Y-1.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
LMAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
LMAT has an Altman-Z score of 25.27. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LMAT (25.27) is better than 95.34% of its industry peers.
LMAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 25.27 |
ROIC/WACC0.98
WACC9.6%
2.3 Liquidity
A Current Ratio of 7.57 indicates that LMAT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.57, LMAT belongs to the top of the industry, outperforming 82.90% of the companies in the same industry.
LMAT has a Quick Ratio of 5.31. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.31, LMAT is in the better half of the industry, outperforming 76.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.57 | ||
| Quick Ratio | 5.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 62.37% over the past year.
The Earnings Per Share has been growing by 8.05% on average over the past years. This is quite good.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.16%.
The Revenue has been growing by 12.87% on average over the past years. This is quite good.
EPS 1Y (TTM)62.37%
EPS 3Y7.46%
EPS 5Y8.05%
EPS growth Q2Q62.96%
Revenue 1Y (TTM)18.16%
Revenue growth 3Y14.35%
Revenue growth 5Y12.87%
Revenue growth Q2Q13.6%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.10% yearly.
Based on estimates for the next years, LMAT will show a small growth in Revenue. The Revenue will grow by 7.86% on average per year.
EPS Next Y25.79%
EPS Next 2Y18.5%
EPS Next 3Y15.1%
EPS Next 5YN/A
Revenue Next Year9.34%
Revenue Next 2Y8.3%
Revenue Next 3Y7.86%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 51.95, which means the current valuation is very expensive for LMAT.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.98% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.60, LMAT is valued quite expensively.
The Price/Forward Earnings ratio is 41.69, which means the current valuation is very expensive for LMAT.
72.02% of the companies in the same industry are more expensive than LMAT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (20.15), we can say LMAT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.95 | ||
| Fwd PE | 41.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 72.02% of the companies are valued more expensively.
LMAT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 79.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.31 | ||
| EV/EBITDA | 31.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 15.10% in the coming years.
PEG (NY)2.01
PEG (5Y)6.46
EPS Next 2Y18.5%
EPS Next 3Y15.1%
5. Dividend
5.1 Amount
With a yearly dividend of 0.82%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.69. LMAT pays more dividend than 92.23% of the companies in the same industry.
With a Dividend Yield of 0.82, LMAT pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 14.87%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.87%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
LMAT pays out 38.10% of its income as dividend. This is a sustainable payout ratio.
The dividend of LMAT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP38.1%
EPS Next 2Y18.5%
EPS Next 3Y15.1%
LEMAITRE VASCULAR INC
NASDAQ:LMAT (5/17/2024, 7:10:56 PM)
After market: 78.45 0 (0%)78.45
+0.77 (+0.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.76B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.95 | ||
| Fwd PE | 41.69 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.01
PEG (5Y)6.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.59% | ||
| ROE | 11.01% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 20.46% | ||
| PM (TTM) | 16.99% | ||
| GM | 66.46% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.57 | ||
| Quick Ratio | 5.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)62.37%
EPS 3Y7.46%
EPS 5Y
EPS growth Q2Q
EPS Next Y25.79%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.16%
Revenue growth 3Y14.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y